Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 津药药业股份有限公司（简称“津药药业”）隶属于天津市医药集团有限公司（简称“医药集团”）， 其前身为1939年创建的天津制药厂，是一家具有80多年历史的大型制药企业。津药药业（曾用名：天药股份）于2001年6月在上海证券交易所上市，股票代码600488。公司现有控股和参股公司17家，总资产规模近67亿元，员工3000余人，是全球知名的皮质激素类药物生产企业和享誉全国的氨基酸原料药生产企业，国家高新技术企业和全国甾体激素行业协会会长单位，为国内急抢救药、冷备药的重要生产基地。 公司在天津滨海新区建有生物园和制剂园两大产业化基地。主要从事皮质激素类、氨基酸类原料药及制剂的研发、生产和销售，主要产品包括地塞米松系列、泼尼松系列、甲泼尼龙系列、倍他米松系列等40余个皮质激素原料药品种，23个氨基酸原料药品种，以及注射剂、软膏剂、乳膏剂、硬胶囊剂、丸剂、冻干粉针剂、吸入制剂、片剂等17个剂型药品。 公司是国内较早获得皮质激素类原料药GMP证书和天津市首批全部通过国家GMP认证的原料药及制剂生产企业。公司皮质激素原料药有60%以上出口到亚洲、欧洲、美洲的70多个国家和地区，国内销售覆盖中国近百个城市，具有较强的市场影响力和占有率。
Main Business 制造经营化学原料药、制造经营原料药（凭许可证经营）、食品添加剂生产、饲料添加剂生产、无菌原料药、中西制剂药品、中药材及中成药加工、医药中间体、化工原料、化妆品、生物柴油及相关技术和原辅材料的加工。
Legal Representative 李书箱
Top Executives
董事长：徐华
董事：徐晓阳,郭珉,刘浩,徐华,李书箱,朱立延
独立董事：霍文逊,陈喆,边泓
Top 5 Shareholder
Shareholder name Nature Holding Date
天津药业集团有限公司流通A股50.69%31/03/2024
津沪深生物医药科技有限公司流通A股5.32%31/03/2024
香港中央结算有限公司流通A股1.65%31/03/2024
钟东明流通A股0.39%31/03/2024
华夏银行股份有限公司－华夏智胜先锋股票型证券投资基金（LOF）流通A股0.37%31/03/2024
Company Secretary 王春丽
Solicitors 天津长实律师事务所
Auditors 中审华会计师事务所（特殊普通合伙）
Tel No 022-60740048
Fax No 022-65277561
Website www.kingyork.biz/html/2/
Email tjpc600488@vip.sina.com
Company Address
Register: 天津开发区西区新业九街19号
Office: 天津开发区黄海路221号
Listing Date 18/06/2001
Shares Capital
Shares Capital: 1,093,932,680
Total A Share: 1,093,932,680
Listed A Share: 1,091,886,680
Non-tradable A Share: 2,046,000
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.107
DPS(RMB)* ¥ 0.087
NBV Per Share(RMB)* ¥ 2.700
Market Capitalization(RMB) 4.379B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources, Nanyang Commercial Bank Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.